At present, society guidelines recommend HCC primary surveillance for patients with chronic hepatitis B (CHB) and cirrhosis, based on abdominal ultrasound (US) evaluation with or without serum alpha-fetoprotein (AFP) levels [34,35,36]. The gene discussed is AFP; the disease is hepatocellular carcinoma.